The model explicitly incorporates nonlinear feedback (IL-10 suppression of TNF-α/IL-6), cross-activation (NF-κB-mediated TNF-α/IL-6 synergy), and empirical parameterization from clinical stroke data. This evidence concerns the gene NFKB1 and Stroke.